Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Policy Omnibus topic
No spam. Unsubscribe anytime.
Senate committee advances amended health omnibus that bars discrimination based on vaccine status and revises medical-marijuana rules
Summary
The Senate Health Policy Committee reported favorably on an amended omnibus health bill that adds a nondiscrimination provision barring denial of care solely for vaccination status, updates medical-marijuana treatment-center definitions and reporting, and drew extended public comment and debate before passing on a committee vote.
The Senate Health Policy Committee on Wednesday advanced Senate Bill 1270 as amended, adding a provision that prohibits health-care providers from denying care solely on the basis of a patient’s vaccination status and making a series of changes to medical-marijuana treatment-center rules and background-screening language.
The amendment to SB 1270 — described on the Senate floor as a wide-ranging “strike-all” that combined multiple changes — also adds vaccination status to a patient bill of rights, requires reporting of theft and diversion by medical marijuana treatment centers, and aligns certain background-screening definitions with federal instructions.
Supporters said the nondiscrimination language fills a gap for patients who say they have been refused care because of vaccine status, while opponents and some committee members warned the provision could force treatment decisions that clinicians now make based on public-health risk or clinical judgment.
“This amendment…says healthcare providers cannot discriminate based on vaccination status. It’s that simple,” said Catherine Henry, who identified herself as a constitutional attorney, during public comment.
Several witnesses told the committee they had direct experience seeking care after vaccine injury or for medically fragile family members. “My son followed the vaccine schedule and had suffered high fevers, Bell’s palsy and regressed into autism,” said Maya Hahn, vice president of REACT and lead for the Maha Florida Coalition for Health Freedom, urging passage of the amendment to protect access to care. Caroline Stancic described serious heart problems she said were linked in a U.S. Army memorandum to an mRNA shot: “I was once extremely healthy and my life will never be the same,” she said.
Critics questioned the scope of the nondiscrimination language and raised practical scenarios in which clinicians might exclude patients for reasons tied to contagious outbreaks or other clinical judgments. “If I’m a doctor and there’s a measles outbreak in my community, and I say that no one can come in my office unless they’ve had a measles vaccination, would I be held liable for discrimination?” Senator Berman asked during debate. Committee members acknowledged the language could require further drafting to reconcile public-health exceptions and malpractice implications.
The bill also contains extensive medical-marijuana provisions added in the amendment: it adjusts definitions for managers and owners, requires licensed centers to report diversion and theft to the Department of Health and law enforcement, and modifies some background-screening and national-database language to align with FBI guidance. Supporters said those updates were needed to maintain access to federal background-check programs and to close regulatory gaps; advocates for patients’ rights urged the health-care nondiscrimination language remain intact.
Longtime critic Ted Macy, identifying himself as a recently retired service member and whistleblower, urged skepticism about the package: “This bill contains 2,510 lines and only 30 of them remotely address health freedom,” he said during public comment, calling for clearer, stand-alone protections for patient choice.
After extended public testimony and debate, the committee approved the amended bill. A roll call showed the measure reported favorably as a committee substitute; the committee chair announced the favorable recommendation on the record.
What’s next: the committee’s favorable recommendation moves the bill to the Senate calendar for further consideration; committee members flagged the nondiscrimination language as a likely subject for additional drafting to clarify clinical exceptions and malpractice implications.
Ending note: SB 1270’s amended combination of patient-rights language and medical-marijuana regulatory changes produced a large volume of public testimony and partisan concern. Committee members said they would continue to work with sponsors to narrow legal and clinical ambiguities before floor action.
